2016, Number 4
<< Back Next >>
Rev Cubana Hematol Inmunol Hemoter 2016; 32 (4)
Health problems in individuals attending in Cienfuegos to donate blood
Sánchez FP, Pérez ULE, Rojo PN, Rodríguez MD, Sánchez BMJ, Bolaños VTT
Language: Spanish
References: 30
Page: 506-517
PDF size: 102.66 Kb.
ABSTRACT
Introduction: Through medical selection and pre-donation screening for hidden
infections post-donation illness or asymptomatic in its early stages, its risk factors or
both are recognized.
Aims: Identify the main health problems in Cienfuegos blood donors.
Methods: A descriptive cross section study with all individuals who came to donate
whole blood in the province of Cienfuegos from 2010 to 2014 was performed. The
analysis units were the donors identified as ineligible to donate blood and those with
positive results in screening tests post-donation.
Results: Tenth of the individuals had a problem or deviation from present or potential
health. The main causes linked to rejection of the donor were: the cloudy appearance
of plasma, alterations in blood pressure levels, hemoglobin concentration outside the
accepted values, infectious diseases or risk factors, use of medicines and other
medical conditions . Also among individuals who donated there was a small proportion
had positive / reactive to infectious test results, fundamentally for antibodies to
hepatitis C.
Conclusions: Although the findings of this study are consistent with most
other authors, the presence of deviations from health in a supposedly healthy
population is significant. Future research should focus on this subject, pointing in the
educational component, policies and selection procedures, counseling and clinical and
epidemiological monitoring of blood donors, among others.
REFERENCES
Ballester-Santovenia JM. ABC DE LA MEDICINA TRANSFUSIONAL. GUÍAS CLÍNICAS. Cuba 2006. La Habana: Ministerio de Salud Pública; 2006. p.111.
Sánchez Frenes P, Fariñas Reinoso AT, Rojo Pérez N, Hernández Malpica S. Diseño de un sistema de vigilancia para infecciones transmitidas por transfusión de sangre en Cienfuegos. Rev Cubana Salud Pública [Internet]. Jun 2011 [citado 08 Dic 2014];37(2):[aprox. 14 p.] Disponible en: http://www.bvs.sld.cu/revistas/spu/vol37_02_11/spu13211.htm
MINSAP. Requisitos para la selección de donantes de sangre. Resolución Ministerial No.101/2008. La Habana: Ministerio de salud Pública; 2008.
Centro para el Control Estatal de Medicamentos, Equipos y Dispositivos Médicos.CECMED Regulación No. M 74-14. Buenas prácticas de fabricación para establecimientos de sangre. La Habana: CECMED; 2014.
World Health Organization [Internet]. Geneva: World Health Organization; 2010. Screening donated blood for transfusion-transmissible infections: recommendations. [Cited 2014 Mar 10]. Available from: http://www.who.int/bloodsafety/ScreeningDonatedBloodforTransfusion.pdf
World Health Organization [Internet]. Geneva: World Health Organization; 2014. Blood Donor Selection.Guidelines on Assessing Donor Suitability for Blood.[Cited 2014 Jun 20]. Available from: https://extranet.who.int/iris/restricted/bitstream/ 10665/76724/1/9789241548519_eng.pdf
MINSAP. Actividades en bancos de sangre y servicios de extracción. Modelo 241- 160-06. 2015. Sistema de información estadística complementaria. La Habana: Ministerio de Salud Pública, Dirección Nacional de Estadística; 2015.
Ballester-SantoveniaJM. El Programa de Medicina Transfusional de Cuba. RevPanam Salud Pública[Internet]. Feb-Mar.2003 [citado 14 Jul 2015];13(2- 3):[aprox 12 p.]. Disponible en: http://www.scielosp.org/scielo.php?pid=S1020- 49892003000200019&script=sci_arttext
Gajjar H, Shah FR, Shah NR, Shah CK. Whole blood donor deferral analysis at General hospital blood bank - A retrospective study. NHL Journal of Medical Sciences [Internet]. Jul 2014 [cited 2015 Oct 22];3:[about 12 s.]. Available from: http://www.nhlmmc.edu.in/document/nhljms%20Volume.3%20Issue.2/72-76.pdf
US Department of Health and Human Services. The 2011 national blood collection and utilization survey report [Internet]. Washington, DC: DHHS; 2013 [citado 11 Mar 2014]. Disponible en: https://www.aabb.org/research/hemovigilance/bloodsurvey/Documents/11-nbcusreport. pdf
Custer B, Schlumpf K, Simon TL, Spencer BR, Wright DJ, Wilkinson SL, et al. Demographics of successful, unsuccessful and deferral visits at six blood centers over a four-year period. Transfusion. 2012 Apr;52(4):712-21. doi: 10.1111/j.1537- 2995.2011.03353.x.
Ngoma AM, Goto A, Sawamura Y, Nollet KE, Ohto H, Yasumura S. Analysis of blood donor deferral in Japan: Characteristics and reasons. Transfus Apher Sci. 2013 Dec;49(3):655-60. doi: 10.1016/j.transci.2013.06.020.
Organización Panamericana de la Salud. Suministro de sangre para transfusiones en los países de Latinoamérica y el Caribe, 2010 y 2011. OPS/OMS Washington, D.C. 2013. Disponible en: http://www.paho.org/hq/index.php?option=com_content&view=article&id=8918%3A 2013-supply-blood-transfusion-caribbean-latin-american-countries-2010- 2011&catid=1163%3Ahss-blood-services-&Itemid=2163&lang=es
World Health OrganizationWHO [Internet]. O Inter-regional Workshop on 'Blood Donor Selection and Donor Counselling' for Priority Countries in the African and Eastern Mediterranean Region. Nairobi: WHO; 27-30 Jun 2011. Available from: http://www.who.int/bloodsafety/WHOCDC_ ReportDonorSelectionCounsellingWorkshopKenya2011.pdf
Prados-Madrona D, Fernández-Herrera MD, Prados-Jiménez D, Gómez-GiraldoS, Robles-Campos R. Women as whole blood donors: offers, donations and deferrals in the province of Huelva, south-western Spain. Blood Transfus.2014 Jan;12(Suppl 1):s11-s20.
Karp JK, King KE.International variation in volunteer whole blood donor eligibility criteria. Transfusion. 2010 Feb;50(2):507-13. doi: 10.1111/j.1537- 2995.2009.02392.x.
Sánchez-Frenes P, Sánchez-Bouza MJ, Mena-Rodríguez E, Seijo-Pérez O, Bastida- GoitizoloO, Castillo-Monzón E. ¿Es útil la prueba de lipemia predonación para la selección de donantes de sangre? Rev Cubana Hematol Inmunol Hemoter. 2014;30(3):265-272.
Benet-Rodríguez M, Morejón-Giraldoni A, Espinosa-Brito A, Landrove-Rodríguez O, Peraza-Alejo D, Orduñez-García P. Factores de Riesgo para Enfermedades Crónicas en Cienfuegos, Cuba 2010. Resultados preliminares de CARMEN II. Medisur[revista en Internet]. 2010 [citado 2016 Abr 28]; 8(2):[aprox. 3 p.]. Disponible en: http://medisur.sld.cu/index.php/medisur/article/view/1166
Peffer K, de Kort WL, Slot E, Doggen CJ. Turbid plasma donations in whole blood donors: fat chance? Transfusion. 2011 Jun;51(6):1179-87. doi: 10.1111/j.1537- 2995.2011.03079.x.
Morales-Borges RH, Merced C. Severe hypertriglyceridemia in Puerto Rico blood donors: a population study 2009-2011 [abstract]. Bol Asoc Med PR. [Internet]. Jul- Sep 2012 [cited 2013 sep 10];[aprox. 1 p.]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23156887
OPS. Elegibilidad para la donación de sangre: Recomendaciones para la educación y la selección de donantes potenciales de sangre. Washington: OPS; 2009.
Ballester-Planes L, Siu MA. Principales causas de rechazo de los donantes de sangre en el banco de sangre provincial de Ciudad de la Habana. Rev Cubana Hematol Inmunol Hemoter [Internet]. 2009 [citado 4 Mar 2015];25(1 sup):[aprox. 8 p.]. Disponible en: http://bvs.sld.cu/revistas/hih/vol25_04_09/hih03409.htm
Alfonso- Rodríguez L. Causas de rechazo de las donaciones de sangre en el bienio 2000-2001. RevCiencias Médicas La Habana [Internet]. 2003 [citado 4 Mar 2015];9(1):[aprox. 8 p.]. Disponible en: http://revcmhabana.sld.cu/index.php/rcmh/article/view/111/html
Gutiérrez- Hernández RC, Vázquez-Del Ángel L. Identificación de los factores de riesgo en donadores de sangre como estrategia para aumentar la calidad en la obtención y la seguridad en la transfusión sanguínea así como la seguridad del dador. Rev Latinoam Patol Clin Med Lab. 2015;62(3):183-6.
Arslan O. Whole blood donor deferral rate and characteristics of the Turkish population.Transfus Med. 2007 Oct;17(5):379-83.
Mantilla-Gutiérrez CY, Cardona-AriasJA. Meta-análisis: prevalencia de deficiencia de hierro en donantes de sangre repetitivos y asociación con sexo, 2001-2011. Rev Cubana Hematol Inmunol Hemoter. 2013;29(1):59-72.
Speedy J, Minck SJ, Marks DC, Bower M, Keller AJ. The challenges de management donor haemoglobin. ISBT Sci Ser. 2011 Dec;6(2):408-15.
Sánchez-Frenes P, Pérez-Ulloa LE, Sánchez-Bouza MJ, González-Álvarez M, Cuellar-Contreras Y, García-Torres D. Evaluación de la concentración de hemoglobina en donantes regulares de plasma. Rev Cubana Hematol Inmunol Hemoter. 2015;31(2):150-159
World Health Organization WHO [Internet]. Ginebra: World Health Organization; 2014. Guidelines for the screening, care and treatment of persons with hepatitis C infection. [Cited 2015 Jun 20]. Available from: http://www.who.int/hiv/pub/hepatitis/hepatitis-c-guidelines/en/
World Health Organization [Internet]. Ginebra: World Health Organization; 2014. Blood donor counseling: implementation guidelines [Cited 2015 Jun 20]. Available from:http://www.ncbi.nlm.nih.gov/books/NBK310584/